MedPath

Effect of Vortioxetine Versus Venlafaxine on Cognitive Functions in Adults with Major Depressive Disorder

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: F32- Major depressive disorder, singleepisode
Registration Number
CTRI/2020/07/026819
Lead Sponsor
AIIMS PATNA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients clinically diagnosed as Major Depressive Disorder.

2.Treatment naive patients or who has not taken any treatment since last 1 month

3. Cooperative & willing to participate

Exclusion Criteria

1.Other depressive spectrum disorders (F34- ---)

2.Highly agitated/ suicidal patients/ depression with psychotic symptoms who need immediate treatment

3.ECT in past 6 months

4.Co-morbid axis I psychiatric illness

5.Patients with co-morbid substance abuse except Nicotine use

6.Patients with known history of diabetes mellitus, hypertension or any long standing significant medical illness / significant neurological impairment (cerebrovascular accidents (CVA) / seizure) / clinical observable mental retardation/ History of organicity that precludes participation in study

7.Pregnant and nursing women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath